Krystal Biotech buy Bank of America Co.
Start price
22.07.25
/
50%
€129.30
Target price
22.07.26
€164.24
Performance (%)
125.52%
End price
23.07.26
€291.60
Summary
This prediction ended on 23.07.26 with a price of €291.60. The BUY prediction by Bank_of_America_Co_ for Krystal Biotech saw massive gains of 125.52%. Bank_of_America_Co_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -12.302% | -12.302% | 100.000% |
| iShares Core DAX® | 2,33 % | 1,01 % | 10,41 % |
| iShares Nasdaq 100 | 1,37 % | -3,61 % | 27,40 % |
| iShares Nikkei 225® | 2,44 % | -7,46 % | 49,84 % |
| iShares S&P 500 | 1,26 % | 0,68 % | 23,67 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Bank of America Corporation from $193.00 to $192.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
76.87%
04.08.26
04.08.26
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€297.90
14.07.26
14.07.26
€347.61
14.07.27
14.07.27
-5.54%
04.08.26
04.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€246.10
22.01.26
22.01.26
€272.02
22.01.27
22.01.27
14.34%
04.08.26
04.08.26